We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADTN icon
676
Adtran
ADTN
$730M
– –
-23,600
Closed -$221K
AHRT
677
AH Realty Trust
AHRT
$540M
– –
-19,658
Closed -$138K
AISP
678
Airship AI Holdings
AISP
$66.5M
– –
-32,277
Closed -$167K
AIT icon
679
Applied Industrial Technologies
AIT
$12.9B
– –
-1,992
Closed -$520K
AKRO
680
DELISTED
Akero Therapeutics
AKRO
– –
-5,016
Closed -$238K
ALGN icon
681
Align Technology
ALGN
$12.6B
– –
-1,677
Closed -$210K
ALIT icon
682
Alight
ALIT
$523M
– –
-4,358
Closed -$284K
ALV icon
683
Autoliv
ALV
$9.09B
– –
-1,780
Closed -$220K
AMBA icon
684
Ambarella
AMBA
$3.03B
– –
-4,153
Closed -$343K
AMH icon
685
American Homes 4 Rent
AMH
$12.2B
– –
-11,239
Closed -$374K
AMPL icon
686
Amplitude
AMPL
$1.16B
– –
-16,257
Closed -$174K
GOLD
687
Gold.com Inc
GOLD
$1.18B
– –
-11,143
Closed -$288K
AMZN icon
688
Amazon
AMZN
$2.48T
– –
-1,176
Closed -$258K
AON icon
689
Aon
AON
$81.4B
– –
-901
Closed -$321K
APAM icon
690
Artisan Partners
APAM
$2.9B
– –
-9,802
Closed -$425K
APLD icon
691
Applied Digital
APLD
$7.61B
– –
-10,647
Closed -$244K
APLS
692
DELISTED
Apellis Pharmaceuticals
APLS
– –
-22,291
Closed -$504K
AQN icon
693
Algonquin Power & Utilities
AQN
$4.68B
– –
-32,897
Closed -$177K
AQST icon
694
Aquestive Therapeutics
AQST
$472M
– –
-46,450
Closed -$260K
ARE icon
695
Alexandria Real Estate Equities
ARE
$9.41B
– –
-2,525
Closed -$210K
ARQT icon
696
Arcutis Biotherapeutics
ARQT
$3.55B
– –
-12,999
Closed -$245K
ARR
697
Armour Residential REIT
ARR
$2.04B
– –
-10,979
Closed -$164K
ARRY icon
698
Array Technologies
ARRY
$785M
– –
-89,560
Closed -$730K
ARTNA icon
699
Artesian Resources
ARTNA
$361M
– –
-6,450
Closed -$210K
ASB icon
700
Associated Banc-Corp
ASB
$5.86B
– –
-13,755
Closed -$354K
26 27
28
29 30

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.